Pentosan Polysulfate vs TB-500
A side-by-side research comparison of Pentosan Polysulfate and TB-500 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Pentosan Polysulfate | TB-500 |
|---|---|---|
| Full name | Pentosan Polysulfate Sodium | Thymosin Beta-4 (Synthetic) |
| Category | Healing & Recovery | Healing & Recovery |
| Status | FDA Approved | Research compound |
| Mechanism | Acts as a glycosaminoglycan analog that coats bladder mucosa, inhibits complement activation, and stimulates proteoglycan synthesis in cartilage. | Upregulates actin production to promote cell migration and proliferation, enhances angiogenesis, and reduces pro-inflammatory cytokines. |
| Molecular weight | 4000-6000 Da (average) | 4921 Da |
| Half-life | ~24 hours | ~6 hours |
| Bioavailability | ~3-6% oral; higher via injection | ~95% via subcutaneous injection |
| Typical dose | 100 mg | 2-5 mg per dose |
| Frequency | 3x daily (oral) | Loading: 2x/week · Maintenance: 1x/week |
| Route | Oral or subcutaneous injection | Subcutaneous injection |
Pentosan Polysulfate reported benefits
- Bladder wall protection
- Cartilage repair support
- Anti-inflammatory action
- Joint pain reduction
TB-500 reported benefits
- Enhanced wound healing
- Reduced inflammation
- Improved flexibility
- Cardiac tissue repair
- Hair regrowth support
Related comparisons
Research and educational reference only. Not medical advice.